Victor V Tatarskiy

18PUBLICATIONS
42CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Proteins and peptidesGene expression (incl. microarray and other genome-wide approaches)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Jan 10, 2026
Pre-Treatment with Dacarbazine Sensitizes B16 Melanoma to CAR T Cell Therapy in Syngeneic Mouse Model.

Egor A Emelianov, Elizaveta R Naberezhnaya, Andrey S Logvinov

|Apr 02, 2025
Knockout of cyclin-dependent kinases 8 and 19 leads to depletion of cyclin C and suppresses spermatogenesis and male fertility in mice.

Alexandra V Bruter, Ekaterina A Varlamova, Nina I Stavskaya

|Feb 15, 2025
CDK8/19 inhibition attenuates G1 arrest induced by BCR-ABL antagonists and accelerates death of chronic myelogenous leukemia cells.

Alvina I Khamidullina, Margarita A Yastrebova, Alexandra V Bruter

|Jan 25, 2025
Re-Sensitization of Resistant Ovarian Cancer SKOV3/CDDP Cells to Cisplatin by Curcumin Pre-Treatment.

Aseel Ali Hasan, Elena Kalinina, Dmitry Zhdanov

|Nov 09, 2024
Disruption of RNA Splicing Increases Vulnerability of Cells to DNA-PK Inhibitors.

Anastasia P Kovina, Artem V Luzhin, Victor V Tatarskiy

|Feb 24, 2024
The Nitro Group Reshapes the Effects of Pyrido[3,4-g]quinazoline Derivatives on DYRK/CLK Activity and RNA Splicing in Glioblastoma Cells.

Sophia S Borisevich, Tatiana E Aksinina, Margarita G Ilyina

Pageof 3

Frequent Collaborators

3 joint publications

Aseel Ali Hasan

3 joint publications

Igor B Roninson

2 joint publications

Elena Kalinina

2 joint publications

Alvina I Khamidullina